Evidence map›Paper›PMID 32707323›Full record

ArticleVascular pharmacology2020

MARCKS mediates vascular contractility through regulating interactions between voltage-gated Ca

Kazi S Jahan, Jian Shi, Harry Z E Greenberg, Sam Khavandi, Miguel Martín-Aragón Baudel, Vincenzo Barrese, Iain A Greenwood, Anthony P Albert

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vascular pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Role for the PIPJournal of cell communication and signaling · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. MARCKS and PI(4,5)PMolecular biology of the cell · 2024
    Article
  7. Article
  8. Peptide Inhibitors of MARCKS Suppress Endotoxin Induced Uveitis in Rats.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Kazi S JahanVascular Biology Research Centre, Molecular and Clinical Research Institute, St. George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
Jian ShiLeeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK.
Harry Z E GreenbergVascular Biology Research Centre, Molecular and Clinical Research Institute, St. George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
Sam KhavandiVascular Biology Research Centre, Molecular and Clinical Research Institute, St. George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
Miguel Martín-Aragón BaudelDepartment of Pharmacology, University of California, 451, Health Sciences Drive, Suite 3503, Davis, CA 95615, USA.
Vincenzo BarreseDepartment of Neurosciences, Reproductive Sciences and Dentistry, University of Naples Federico II, Corso Umberto I, 40, 80138 Napoli, NA, Italy.
Iain A GreenwoodVascular Biology Research Centre, Molecular and Clinical Research Institute, St. George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
Anthony P AlbertVascular Biology Research Centre, Molecular and Clinical Research Institute, St. George's, University of London, Cranmer Terrace, London SW17 0RE, UK. Electronic address: aalbert@sgul.ac.uk.
St George's, University of London · GBUniversity of California, Davis · USUniversity of Leeds · GBUniversity of Naples Federico II · IT

Funding

Biotechnology and Biological Sciences Research Council BB/J007226/1Biotechnology and Biological Sciences Research Council BB/M018350/1British Heart Foundation FS/13/10/30021British Heart Foundation FS/15/44/31570British Heart Foundation FS/17/2/32559British Heart Foundation PG/18/69/33870
6 · The paper itself

Abstract

Phosphatidylinositol 4,5-bisphosphate (PIP

Indexed as

VasoconstrictionAnimalsCalcium Channel BlockersCalcium Channels, L-TypeMesenteric Artery, SuperiorMice, 129 StrainMuscle, Smooth, VascularMyristoylated Alanine-Rich C Kinase SubstratePeptide FragmentsPhosphatidylinositol 4,5-DiphosphateRats, WistarSignal TransductionVasoconstrictor AgentsCACNA1C protein, mouseCacna1c protein, ratCalcium Channel BlockersCalcium Channels, L-TypeMarcks protein, mouseMarcks protein, ratMARCKS-related peptideMyristoylated Alanine-Rich C Kinase SubstratePeptide FragmentsPhosphatidylinositol 4,5-DiphosphateVasoconstrictor AgentsContractilityMARCKSPIP(2)Voltage-gated Ca(2+) channels

Identifiers

PMID32707323
PMCPMC7549404
OpenAlexW3044858359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.